Absolute number of circulating T lymphocytes (× 106/L) and CD4/CD8 T-cell subset ratio in 20 highly stable, untreated CLL patients
. | Mean ± SD . | . | Median . | . | Range . | . | |||
|---|---|---|---|---|---|---|---|---|---|
. | Patients . | Controls . | Patients . | Controls . | Patients . | Controls . | |||
| CD3 | 2147 ± 1479 | 1048 ± 300 | 1447 | 1029 | 593-6265 | 519-1739 | |||
| CD4 | 1690 ± 1588 | 602 ± 196 | 994 | 576 | 420-5728 | 276-1047 | |||
| CD8 | 732 ± 550 | 400 ± 155 | 600 | 382 | 257-2506 | 151-711 | |||
| CD4/CD8 ratio | 2.28 ± 1.00 | 1.71 ± 0.77 | 2.09 | 1.64 | 1.00-4.40 | 0.97-4.05 | |||
. | Mean ± SD . | . | Median . | . | Range . | . | |||
|---|---|---|---|---|---|---|---|---|---|
. | Patients . | Controls . | Patients . | Controls . | Patients . | Controls . | |||
| CD3 | 2147 ± 1479 | 1048 ± 300 | 1447 | 1029 | 593-6265 | 519-1739 | |||
| CD4 | 1690 ± 1588 | 602 ± 196 | 994 | 576 | 420-5728 | 276-1047 | |||
| CD8 | 732 ± 550 | 400 ± 155 | 600 | 382 | 257-2506 | 151-711 | |||
| CD4/CD8 ratio | 2.28 ± 1.00 | 1.71 ± 0.77 | 2.09 | 1.64 | 1.00-4.40 | 0.97-4.05 | |||